California · Nonprofit
SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS
SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS (California) receives grants from 3 organizations whose IRS filings report $19,246 to it, the largest being THE PFIZER FOUNDATION INC ($11,650). 1 of them have funded it in more than one year.
- Revenue FY2024
- $263k
- Funders on record
- 3
- Grants received
- $19k
- Net assets
- $422k
What Socal Association for Biomedical and Pharmaceutical Advancements does
Mission
Sabpa's primary mission and most significant activities are to promote science and innovation. (1). To provide forums for facilitating interaction and communcations among biotechinal proessionalsionals in glboal science and technology arena;(2). To promote interaction and collaboration in science and technology across the pacific regions; and(3). To stimulate and nurture the innovative ideas, cutting-edge technologies, entrepreneurship and bringing public awareness of the benefits of biomedical research.
As stated on its FY2024 Form 990.
Programs
The 20th San Diego SABPA BioPharma Conference (October 5, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CAFor the past 20 years, San Diego BioPharma Conference, the flagship event of SABPA, has witnessed the boom of the pharmaceuticals and biotechnology industry in one of the nation's premier innovation centers. From potential Nobel laureates and technologically disruptive inventors to entrepreneurs and multi-billion-dollar dealmakers, this annual conference has been featuring some of the most respectful figures in the fields. This year, the long-awaited in-person conference is back.Program highlights are as follows:1. Fireside Chats on Taking a Research Organization towards Commercialization2. Breakthrough Prize Winner achievements in Serial Innovation in Drug Development3. The journey From Academia to Industry in Neuroscience IPOs4. Discovering the transformative impact of Moores Cancer Center's New Director, a world-renowned Pancreatic SurgeonDelving into cutting-edge innovations like Next-Gen Chemo proteomics Platforms
$127,897 spent$119,998 earned by the program58% of program spendingThe 8th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum (March 23, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CASABPA FTD annually brings together the latest in groundbreaking research, cutting-edge drugs, and industry trends within the biopharma sector. The event's broad spectrum of topics provides a platform for local biotech companies to engage in vibrant discussions and valuable networking opportunities. The forthcoming 8th FTD Conference was set to shine a spotlight on three revolutionary domains in the field of metabolism disease and oncology: Glucagon-like peptide-1 (GLP-1), Antibody-Drug Conjugates (ADC), and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics. Program highlights are as follows:1. GLP-1 receptor agonists, from diabetes to obesity and beyond2. The rise of ADC - a biological missile, for targeted cancer therapy3. Reinventing drug discovery with AI-powered automation4. Frontiers in MRD detection to increase chance of cancer cure
$72,008 spent$66,077 earned by the program33% of program spendingSABPA OC/LA 16th Annual Biomedical Forum (April 20, 2024)Address: The Beckman Center, 100 Academy, Irvine, CA, 92617SABPA OC/LA annually brings together the latest innovations in biomedical industries, cutting-edge developments of pharmaceuticals and medical devices, entrepreneurship, and career development. The event's broad spectrum of topics provides a platform for local biotech and medical device companies to engage in vibrant discussions and valuable networking opportunities.
$18,994 spent$19,406 earned by the program9% of program spending
The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $218,899.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $324k to $373k (+15%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
18% of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS’s revenue is contributions — about as donation-reliant as the typical peer (79% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2020 → 2023: the base held at 1 funder, grant income rose $1k → $4k.
1 of 3 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 34% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS leans on a few funders — its largest provides 61% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
34% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS.
Largest funder’s share by year: 2020 100% · 2021 100% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS draws 100% of its grant income from funders outside California, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $7k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS holds deeper cash reserves than three-quarters of the 793 science & tech nonprofits its size.
this organization peer median middle 50% of peers· 793 science & tech nonprofits $100k–$1M, FY2024
Organizations like SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
96% of spending goes to programs.
Governance
Public support
91%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS?
- SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS (California) receives grants from 3 organizations whose IRS filings report $19,246 to it, the largest being THE PFIZER FOUNDATION INC ($11,650). 1 of them have funded it in more than one year.
- How many funders does SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS have?
- IRS filings report 3 organizations giving $19,246 in grants to SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS, 1 of which have funded it in more than one year.
- Who is the largest funder of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS?
- THE PFIZER FOUNDATION INC is the largest funder on record, with $11,650 in grants. The full list of funders is on this page.
- How can an organization like SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Socal Association for Biomedical and Pharmaceutical Advancements →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 3 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing